Cancer Research Articles

Florida Cancer Specialists & Research Institute (FCS), is pleased to announce that radiation oncologist, Kunal Saigal, MD will lead the new Sarasota Memorial Radiation Oncology Center, which opens August 3, 2020. The 18,000 square foot outpatient radiation center completes the first phase of the planned community Cancer Institute by Sarasota Memorial Health Care System (SMH), boasting two Varian TrueBeam linear accelerators, which are considered the gold standard for radiation oncology.

Florida Cancer Specialists & Research Institute (FCS), recently cut the ribbon on a new state-of-the-art facility at 1396 Whisper Circle, Sebring, FL to provide comprehensive treatments and a variety of services to adults with cancer and other diseases. The new location replaces the existing FCS clinic at 4420 Sun-N-Lake Blvd. in Sebring.

Florida Cancer Specialists & Research Institute (“FCS” or the “Company”), announced that FCS Chief Financial Officer Nathan H. Walcker has been named Chief Executive Officer, effective August 1, 2020. Walcker will succeed current Chief Executive Officer Brad Prechtl, MBA, who will retire from FCS, effective July 30, 2020, but continue to serve as a consultant through April 2021.

Lucio Gordan, MD, will lead an educational session at the Community Oncology Advocacy Summit Scheduled for July 15, 2020.

Florida Cancer Specialists & Research Institute (FCS) recently celebrated the start of construction of its new Trinity Cancer Center. When complete in early 2021, the 37,000 square foot facility will include radiation oncology and next-generation PET/CT imaging technology along with 27 exam rooms and 52 chairs for chemotherapy and other infusions. Patients will also have access to participate in cutting-edge clinical trial research.

Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the opening of a new office location in Middleburg, Florida on June 1, 2020. FCS currently has a clinic location in Fleming Island, making the Middleburg site its second location in the greater Jacksonville area.

Melody Chang, RPh, MBA, BCOP, director of pharmacy operations for Florida Cancer Specialists & Research Institute (FCS), has published an article concerning the ongoing controversy surrounding the treatment of cancer patients with medical marijuana or other cannabinoid-derived products.

Florida Cancer Specialists & Research Institute (FCS) physicians are the co-authors of 20 research studies that will be presented at the American Society of Clinical Oncology (ASCO®) ASCO20 Virtual Scientific Program being held May 29 – 31, 2020.